SEC Form 4 · accession 0001213900-18-008738
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Neitzel
Director
Period of report
Jun 30, 2018
Accepted (ET)
Jul 3, 2018 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF1,F2 | — | Jun 30, 2018 | A | 893 | A | Jun 30, 2018 | Jun 30, 2022 | COMMON STOCK | 893 | 893 | D |
Explanation of responses
- F1Pursuant to the Reporting Person's appointment as Director, on June 30, 2018, the Issuer granted to Reporting Person an option (the "Option") to purchase 893 shares of the Issuer's restricted common stock, with an exercise price of $20.00 per share. The term of the Option is for a period of four (4) years from the date of issuance.
- F2The Option will be issued and become exercisable upon an increase in the number of shares reserved under the Issuer's 2016 Omnibus Incentive Plan.